A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells Juan A. MarchalMaría C. NúñezJoaquín M. Campos Preclinical Study 24 November 2006 Pages: 237 - 246
JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells Nedret AltiokMeral KoyuturkSoner Altiok Preclinical Study 23 December 2006 Pages: 247 - 254
Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer Hilmi OzcelikDushanthi PinnaduwageIrene L. Andrulis Preclinical Study 13 January 2007 Pages: 255 - 265
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses Antonio RussoValentina CalòViviana Bazan Preclinical study 13 January 2007 Pages: 267 - 276
Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells Yunfei ZhangBaoan MaQingyu Fan Preclinical Study 23 December 2006 Pages: 277 - 286
N-cadherin engagement provides a dominant stop signal for the migration of MDA-MB-468 breast carcinoma cells S. PotthoffF. EntschladenK. Lang Preclinical Study 14 December 2006 Pages: 287 - 295
Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells Leslie Hodges-GallagherCathleen D. ValentinePeter J. Kushner Preclinical Study 21 December 2006 Pages: 297 - 309
The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma Friedrich OtterbachRainer CalliesKurt W. Schmid Preclinical Study 21 December 2006 Pages: 311 - 317
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro Richard S. FinnJudy DeringDennis J. Slamon Preclinical Study Open access 01 February 2007 Pages: 319 - 326
ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States Martha L. SlatteryCarol SweeneyTim Byers Epidemiology 23 December 2006 Pages: 327 - 335
Serum prolactin levels are positively associated with mammographic density in postmenopausal women Gail A. GreendaleMei-Hua HuangArun Karlamangla Epidemiology 27 January 2007 Pages: 337 - 346
Survival after bilateral breast cancer: results from a population-based study Helena M. VerkooijenVanessa ChatelainPierre O. Chappuis Epidemiology 21 December 2006 Pages: 347 - 357
Leukemia following breast cancer: an international population-based study of 376,825 women Regan A. HowardEthel S. GilbertLois B. Travis Epidemiology 13 January 2007 Pages: 359 - 368
Impact of a programme of mass mammography screening for breast cancer on socio-economic variation in survival: a population-based study W. J. LouwmanL. V. van de Poll-FranseJ. W. W. Coebergh Epidemiology Open access 09 January 2007 Pages: 369 - 375
Mutation analysis of five candidate genes in familial breast cancer Anna MarshSue HealeyGeorgia Chenevix-Trench Original Article 23 December 2006 Pages: 377 - 389